* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:41L vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorios Farmaceuticos Rovi OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Laboratorios Farmaceuticos Rovi's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi (STU:41L) has a OCF Margin % of 8.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. This is 34% below median its historical median of 12.80. According to the industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #251 out of 959 companies in the Drug Manufacturers industry, placing it in the top 26.2%.
Is Laboratorios Farmaceuticos Rovi's OCF Margin % too high?
Laboratorios Farmaceuticos Rovi's current OCF Margin % of 8.50% is 34% below median its 10-year median of 12.80. The Drug Manufacturers industry median OCF Margin % is 9.95. Laboratorios Farmaceuticos Rovi's value of 8.50% is 14.6% below this industry median. Based on the distribution chart, Laboratorios Farmaceuticos Rovi ranks #251 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 99/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #251 out of 959 companies for OCF Margin %. This puts Laboratorios Farmaceuticos Rovi in the upper half of its industry. The industry median OCF Margin % is 9.95. Laboratorios Farmaceuticos Rovi's value of 8.50% is 14.6% below this benchmark. While the company's 10-year median is 12.80 vs. the industry median of 9.95, Laboratorios Farmaceuticos Rovi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laboratorios Farmaceuticos Rovi's current OCF Margin % of 8.50% is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorios Farmaceuticos Rovi's current OCF Margin % is 8.50%, which is 34% below median its own 10-year median of 12.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi (STU:41L) is currently considered Fairly Valued. The stock's GF Value™ is €53.69, compared to a current price of €59.25 — trading 10.4% above its estimated fair value. The current OCF Margin % is 8.50%, which is 34% below median its 10-year median of 12.80 and 14.6% below the Drug Manufacturers industry median of 9.95. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (STU:41L), the current OCF Margin % is 8.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (STU:41L) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of €59.25 is trading 10.4% above its estimated GF Value™ of €53.69.
GuruFocus considers Laboratorios Farmaceuticos Rovi to be Fairly Valued.
Key valuation signals for STU:41L:
OCF Margin %: 8.50% (34% below median its 10-year median of 12.80)
GF Value™: €53.69 vs. price of €59.25 (10.4% above fair value)
Industry Position: 14.6% below the Drug Manufacturers median (#251 of 959)
No single metric tells the full story. See the STU:41L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi Business Description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
99GF Score
Get the complete analysis for STU:41L
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:41L has been successfully added to your 
